(19)
(11) EP 2 585 595 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.09.2017 Bulletin 2017/39

(45) Mention of the grant of the patent:
16.08.2017 Bulletin 2017/33

(21) Application number: 11731485.6

(22) Date of filing: 23.06.2011
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
(86) International application number:
PCT/GB2011/051185
(87) International publication number:
WO 2011/161460 (29.12.2011 Gazette 2011/52)

(54)

RNA MOLECULES AND USES THEREOF

RNA-MOLEKÜLE UND IHRE VERWENDUNG

MOLÉCULES D'ARN ET LEURS UTILISATIONS


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 23.06.2010 GB 201010557

(43) Date of publication of application:
01.05.2013 Bulletin 2013/18

(73) Proprietor: MiNA Therapeutics Limited
London, W12 0BZ (GB)

(72) Inventor:
  • SÆTROM, Pål
    NO-7023 Trondheim (NO)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)


(56) References cited: : 
WO-A1-2010/047216
WO-A2-2009/046397
   
  • KEVIN V. MORRIS ET AL: "Bidirectional Transcription Directs Both Transcriptional Gene Activation and Suppression in Human Cells", PLOS GENETICS, vol. 4, no. 11, 1 January 2008 (2008-01-01), page E1000258, XP055008804, ISSN: 1553-7390, DOI: 10.1371/journal.pgen.1000258
  • LI LONG-CHENG ET AL: "Small dsRNAs induce transcriptional activation in human cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC; US, vol. 103, no. 46, 14 November 2006 (2006-11-14), pages 17337-17342, XP002589998, ISSN: 0027-8424, DOI: 10.1073/PNAS.0607015103 [retrieved on 2006-11-03]
  • SCHWARTZ J C ET AL: "Antisense transcripts are targets for activating small RNAs", NATURE STRUCTURAL & MOLECULAR BIOLOGY,, vol. 15, no. 8, 6 July 2008 (2008-07-06), pages 842-848, XP009109339, ISSN: 1545-9985, DOI: 10.1038/NSMB.1444
  • PLACE ROBERT F ET AL: "MicroRNA-373 induces expression of genes with complementary promoter sequences", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC; US, vol. 105, no. 5, 5 February 2008 (2008-02-05), pages 1608-1613, XP002548636, ISSN: 0027-8424, DOI: 10.1073/PNAS.0707594105 [retrieved on 2008-01-28]
  • NA XU ET AL: "MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells", CELL, vol. 137, no. 4, 1 May 2009 (2009-05-01), pages 647-658, XP055008854, ISSN: 0092-8674, DOI: 10.1016/j.cell.2009.02.038
  • JANOWSKI B A ET AL: "Activating gene expression in mammalian cells with promoter-targeted duplex RNAs", NATURE CHEMICAL BIOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 3, no. 3, 28 January 2007 (2007-01-28), pages 166-173, XP003026584, ISSN: 1552-4450, DOI: 10.1038/NCHEMBIO860
  • ELMÉN J ET AL: "Antagonism of microRNA-122 in mice by sistemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 36, no. 4, 23 December 2007 (2007-12-23), pages 1153-1162, XP002533568, ISSN: 0305-1048, DOI: 10.1093/NAR/GKM1113
  • Y. TIAN ET AL: "MicroRNA-10b Promotes Migration and Invasion through KLF4 in Human Esophageal Cancer Cell Lines", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 285, no. 11, 12 March 2010 (2010-03-12), pages 7986-7994, XP055008850, ISSN: 0021-9258, DOI: 10.1074/jbc.M109.062877
  • SARA NAPOLI ET AL: "Promoter-specific transcriptional interference and c-myc gene silencing by siRNAs in human cells", THE EMBO JOURNAL, vol. 28, no. 12, 17 June 2009 (2009-06-17) , pages 1708-1719, XP055009047, ISSN: 0261-4189, DOI: 10.1038/emboj.2009.139
  • KALANTARI ROYA ET AL: "Regulation of mammalian transcription and splicing by Nuclear RNAi", NUCLEIC ACIDS RESEARCH, vol. 44, no. 2, January 2016 (2016-01), pages 524-537, ISSN: 0305-1048(print)
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).